CervoMed Inc.

NASDAQ: CRVO
Share price (3/28/25): $9.48
Market cap (3/28/25): $82.5 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement

Prospectus supplement

Shelf registration

Updated info for already-effective prospectus

Ownership Filter

Gregoire Sylvie

Elder William Robert

Cobuzzi Robert Joseph Jr.

Blackburn Kelly

News Filter

Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Updates

Material Disclosure

Announces Positive Results From the Extension Phase of Its Phase 2b Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies

Provides Update on Neflamapimod DLB Program as Part of Presentation at the 8th International Lewy Body Dementia Conference

Announces Topline Data From RewinD-LB Phase 2b Clinical Trial in Patients With Dementia With Lewy Bodies

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Revised preliminary proxy by non-management

Proxy in contested situation

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness